Shionogi Pharma, Inc.
Shionogi Pharma, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America. Founded in 1878, Shionogi has established itself as a leader in developing innovative therapies, particularly in the fields of infectious diseases, pain management, and central nervous system disorders. The company is renowned for its unique approach to drug development, focusing on both prescription medications and over-the-counter products that address unmet medical needs. Notable achievements include the successful launch of several key therapies that have significantly improved patient outcomes. With a commitment to research and development, Shionogi Pharma continues to strengthen its market position, contributing to advancements in healthcare and enhancing the quality of life for patients worldwide.
DitchCarbon Score
How does Shionogi Pharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shionogi Pharma, Inc.'s score of 35 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shionogi Pharma, Inc.'s reported carbon emissions
Shionogi Pharma, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the pharmaceutical industry is increasingly focusing on reducing carbon footprints and enhancing environmental responsibility. As such, Shionogi Pharma may be engaging in industry-standard practices to address climate change, although specific details are not provided.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shionogi Pharma, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
